Results 281 to 290 of about 417,168 (325)

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Evaluating the Construct Validity of the Charité Alarm Fatigue Questionnaire using Confirmatory Factor Analysis.

open access: yesJMIR Hum Factors
Wunderlich MM   +11 more
europepmc   +1 more source

The factor structure of the International Trauma Questionnaire - Heywood cases in confirmatory factor analysis. [PDF]

open access: yesEur J Psychotraumatol
Karstoft KI   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy